Showing results (21-30 of 1,072) with videos related to

Sort By:
Pageof 108
Giornale Italiano Di Cardiologia (2006)|May 13, 2011
[Antiplatelet and anticoagulant therapy in elderly patients]Davide Capodanno, Dominick J Angiolillo, Corrado Tamburino
European Heart Journal|December 2, 2009
Platelet thrombin receptor antagonism and atherothrombosisDominick J Angiolillo, Davide Capodanno, Shinya Goto
Therapeutic Advances in Cardiovascular Disease|December 12, 2019
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical useDavide Capodanno, Rocco P Milluzzo, Dominick J Angiolillo
Future Cardiology|February 3, 2021
Canakinumab for secondary prevention of coronary artery diseaseLuis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|October 17, 2022
Approaches to de-escalation of antiplatelet treatment in stabilized post-myocardial infarction patients with high ischemic riskPlacido Maria Mazzone, Dominick J Angiolillo, Davide Capodanno
Expert Opinion on Drug Safety|August 5, 2023
Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromesGiovanni Occhipinti, Antonio Greco, Dominick J Angiolillo, et al.
Expert Opinion on Pharmacotherapy|January 24, 2023
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationAntonio Greco, Simone Finocchiaro, Dominick J Angiolillo, et al.
Expert Review of Cardiovascular Therapy|August 7, 2019
Aspirin for the primary prevention of cardiovascular disease: latest evidenceDavide Capodanno, Salvatore Ingala, Dario Calderone, et al.
Expert Opinion on Drug Safety|October 19, 2019
Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigmsSergio Buccheri, Davide Capodanno, Stefan James, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCIAntonio Greco, Maria Sara Mauro, Davide Capodanno, et al.
Pageof 108